Role of sodium-glucose cotransporter 2 inhibitors in cardiovascular events in patients with heart failure
Heart failure is a major cause of morbidity and mortality globally, with a significant impact on both patients’ quality of life and healthcare costs. Sodium-glucose cotransporter 2 inhibitors (SGLT2-I), initially developed for the treatment of type 2 diabetes mellitus, have attracted particular int...
Saved in:
| Main Authors: | Eva Muja, Letizia Giuseppina Floccari, Artan Simaku, Klodeta Grosha, Besim Lama, Ilirian Laçi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2025-07-01
|
| Series: | Italian Journal of Medicine |
| Subjects: | |
| Online Access: | https://www.italjmed.org/ijm/article/view/1997 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unmasking of normocalcemic primary hyperparathyroidism after sodium-glucose cotransporter-2 inhibitor initiation
by: Christodoulos Dolapsakis, et al.
Published: (2025-01-01) -
Timing and Adherence Matter for Sodium–Glucose Cotransporter‐2 Inhibitors in Heart Failure
by: Mehmet Birhan Yilmaz, et al.
Published: (2025-04-01) -
Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Calcium Homeostasis: Where We Stand Now
by: Alessandro Cuttone, et al.
Published: (2025-05-01) -
Effect of Sodium-Glucose Cotransporter Type 2 Inhibitors on The Development and Course of Atrial Fibrillation
by: D. A. Ishmaev, et al.
Published: (2025-01-01) -
Sodium glucose cotransporter 2 inhibitors are associated with renal stabilization in heart transplantation
by: Lisa M. Raven, MBBS, FRACP, et al.
Published: (2025-05-01)